GeneMatrix Inc. (KOSDAQ:109820)

GeneMatrix Statistics

Total Valuation

GeneMatrix has a market cap or net worth of KRW 50.37 billion.

Market Cap	50.37B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

GeneMatrix has 20.39 million shares outstanding.

Current Share Class	20.39M
Shares Outstanding	20.39M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+10.69%
Owned by Insiders (%)	15.95%
Owned by Institutions (%)	0.01%
Float	17.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.67
PB Ratio	3.24
P/TBV Ratio	3.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.70.

Current Ratio	2.02
Quick Ratio	1.80
Debt / Equity	0.70
Debt / EBITDA	n/a
Debt / FCF	-3.74
Interest Coverage	-4.12

Financial Efficiency

Return on equity (ROE) is -15.62% and return on invested capital (ROIC) is -6.71%.

Return on Equity (ROE)	-15.62%
Return on Assets (ROA)	-6.05%
Return on Invested Capital (ROIC)	-6.71%
Return on Capital Employed (ROCE)	-12.57%
Revenue Per Employee	152.32M
Profits Per Employee	-67.52M
Employee Count	31
Asset Turnover	0.17
Inventory Turnover	2.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.26% in the last 52 weeks. The beta is 1.58, so GeneMatrix's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	-25.26%
50-Day Moving Average	2,577.80
200-Day Moving Average	2,626.95
Relative Strength Index (RSI)	40.49
Average Volume (20 Days)	132,710

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GeneMatrix had revenue of KRW 4.72 billion and -2.09 billion in losses. Loss per share was -123.85.

Revenue	4.72B
Gross Profit	1.79B
Operating Income	-2.63B
Pretax Income	-1.97B
Net Income	-2.09B
EBITDA	-2.14B
EBIT	-2.63B
Loss Per Share	-123.85

Balance Sheet

The company has 11.87 billion in cash and 10.83 billion in debt, giving a net cash position of 1.04 billion or 50.89 per share.

Cash & Cash Equivalents	11.87B
Total Debt	10.83B
Net Cash	1.04B
Net Cash Per Share	50.89
Equity (Book Value)	15.53B
Book Value Per Share	830.38
Working Capital	8.19B

Cash Flow

In the last 12 months, operating cash flow was -2.24 billion and capital expenditures -651.33 million, giving a free cash flow of -2.89 billion.

Operating Cash Flow	-2.24B
Capital Expenditures	-651.33M
Free Cash Flow	-2.89B
FCF Per Share	-141.95

Margins

Gross margin is 37.83%, with operating and profit margins of -55.67% and -44.33%.

Gross Margin	37.83%
Operating Margin	-55.67%
Pretax Margin	-41.71%
Profit Margin	-44.33%
EBITDA Margin	-45.41%
EBIT Margin	-55.67%
FCF Margin	n/a

Dividends & Yields

GeneMatrix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.60%
Shareholder Yield	-65.60%
Earnings Yield	-4.16%
FCF Yield	-5.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 24, 2018. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 24, 2018
Split Type	Forward
Split Ratio	1.5

Scores

GeneMatrix has an Altman Z-Score of 2.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.17
Piotroski F-Score	2